Medifast, Inc.
MED
$12.90
-$0.22-1.68%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 543.45M | 602.46M | 674.48M | 770.18M | 897.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 543.45M | 602.46M | 674.48M | 770.18M | 897.81M |
| Cost of Revenue | 141.88M | 157.84M | 176.70M | 200.71M | 241.06M |
| Gross Profit | 401.58M | 444.62M | 497.77M | 569.48M | 656.75M |
| SG&A Expenses | 403.40M | 437.24M | 482.53M | 530.63M | 571.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 549.78M | 599.58M | 663.63M | 735.93M | 816.98M |
| Operating Income | -6.32M | 2.88M | 10.85M | 34.25M | 80.83M |
| Income Before Tax | -7.27M | 3.79M | 12.32M | 37.29M | 87.05M |
| Income Tax Expenses | -275.00K | 1.70M | 4.99M | 7.96M | 19.29M |
| Earnings from Continuing Operations | -7.00 | 2.09 | 7.33 | 29.33 | 67.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.00M | 2.09M | 7.33M | 29.33M | 67.76M |
| EBIT | -6.32M | 2.88M | 10.85M | 34.25M | 80.83M |
| EBITDA | 12.51M | 21.69M | 20.64M | 47.34M | 94.23M |
| EPS Basic | -0.64 | 0.19 | 0.67 | 2.69 | 6.22 |
| Normalized Basic EPS | -0.42 | 0.22 | 0.71 | 2.14 | 4.99 |
| EPS Diluted | -0.65 | 0.18 | 0.66 | 2.68 | 6.20 |
| Normalized Diluted EPS | -0.42 | 0.21 | 0.70 | 2.13 | 4.98 |
| Average Basic Shares Outstanding | 43.76M | 43.72M | 43.68M | 43.63M | 43.58M |
| Average Diluted Shares Outstanding | 43.84M | 43.85M | 43.80M | 43.76M | 43.74M |
| Dividend Per Share | -- | -- | 0.00 | 1.65 | 3.30 |
| Payout Ratio | -2.84% | 34.18% | 255.16% | 125.26% | 80.52% |